ES2597846T3 - Concentrado de emulsión - Google Patents
Concentrado de emulsión Download PDFInfo
- Publication number
- ES2597846T3 ES2597846T3 ES07786569.9T ES07786569T ES2597846T3 ES 2597846 T3 ES2597846 T3 ES 2597846T3 ES 07786569 T ES07786569 T ES 07786569T ES 2597846 T3 ES2597846 T3 ES 2597846T3
- Authority
- ES
- Spain
- Prior art keywords
- acid
- derivatives
- water
- emulsion
- emulsion concentrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000839 emulsion Substances 0.000 title abstract description 26
- 239000012141 concentrate Substances 0.000 title abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 7
- 239000007957 coemulsifier Substances 0.000 abstract description 5
- 239000003995 emulsifying agent Substances 0.000 abstract description 5
- 229920005862 polyol Polymers 0.000 abstract description 4
- 150000003077 polyols Chemical class 0.000 abstract description 4
- 239000012223 aqueous fraction Substances 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 description 12
- -1 2-oxo-3-bornyliden Chemical class 0.000 description 11
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 10
- 239000000306 component Substances 0.000 description 10
- 239000012071 phase Substances 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 7
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 239000011787 zinc oxide Substances 0.000 description 5
- 239000002245 particle Substances 0.000 description 4
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical class CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000008271 cosmetic emulsion Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910044991 metal oxide Inorganic materials 0.000 description 2
- 150000004706 metal oxides Chemical class 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- CQOVPNPJLQNMDC-SSDOTTSWSA-N (2r)-2-(3-aminopropanoylamino)-3-(1h-imidazol-5-yl)propanoic acid Chemical compound NCCC(=O)N[C@@H](C(O)=O)CC1=CNC=N1 CQOVPNPJLQNMDC-SSDOTTSWSA-N 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- RMSGQZDGSZOJMU-UHFFFAOYSA-N 1-butyl-2-phenylbenzene Chemical group CCCCC1=CC=CC=C1C1=CC=CC=C1 RMSGQZDGSZOJMU-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- FRGIOIALHUOUTR-UHFFFAOYSA-N 2-[4-(diethylamino)-2-hydroxybenzoyl]hexyl benzoate Chemical compound C=1C=C(N(CC)CC)C=C(O)C=1C(=O)C(CCCC)COC(=O)C1=CC=CC=C1 FRGIOIALHUOUTR-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 1
- DXPQDAHFCMBFMM-UHFFFAOYSA-N 2-benzoylbenzenesulfonic acid Chemical class OS(=O)(=O)C1=CC=CC=C1C(=O)C1=CC=CC=C1 DXPQDAHFCMBFMM-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ODJQKYXPKWQWNK-UHFFFAOYSA-N 3,3'-Thiobispropanoic acid Chemical compound OC(=O)CCSCCC(O)=O ODJQKYXPKWQWNK-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 description 1
- NGIJJKCNSNMZLK-UHFFFAOYSA-N 3-oxo-3-(4-propan-2-ylphenyl)propanal Chemical compound CC(C)C1=CC=C(C(=O)CC=O)C=C1 NGIJJKCNSNMZLK-UHFFFAOYSA-N 0.000 description 1
- KKJKXQYVUVWWJP-UHFFFAOYSA-N 4-[(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanylidene)methyl]benzenesulfonic acid Chemical compound CC1(C)C2CCC1(C)C(=O)C2=CC1=CC=C(S(O)(=O)=O)C=C1 KKJKXQYVUVWWJP-UHFFFAOYSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 108010085443 Anserine Proteins 0.000 description 1
- XHVAWZZCDCWGBK-WYRLRVFGSA-M Aurothioglucose Chemical compound OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O XHVAWZZCDCWGBK-WYRLRVFGSA-M 0.000 description 1
- GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 description 1
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- LAAPRQODJPXAHC-UHFFFAOYSA-N Coniferyl benzoate Natural products C1=C(O)C(OC)=CC(C=CCOC(=O)C=2C=CC=CC=2)=C1 LAAPRQODJPXAHC-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 101001061807 Homo sapiens Rab-like protein 6 Proteins 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- SLRNWACWRVGMKD-UHFFFAOYSA-N L-anserine Natural products CN1C=NC(CC(NC(=O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-UHFFFAOYSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical class [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 241000210053 Potentilla elegans Species 0.000 description 1
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 1
- 102100029618 Rab-like protein 6 Human genes 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 239000003490 Thiodipropionic acid Substances 0.000 description 1
- 102000002933 Thioredoxin Human genes 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- MYYIAHXIVFADCU-QMMMGPOBSA-N anserine Chemical compound CN1C=NC=C1C[C@H](NC(=O)CC[NH3+])C([O-])=O MYYIAHXIVFADCU-QMMMGPOBSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940071097 ascorbyl phosphate Drugs 0.000 description 1
- 229960001799 aurothioglucose Drugs 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 description 1
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- DRVWBEJJZZTIGJ-UHFFFAOYSA-N cerium(3+);oxygen(2-) Chemical class [O-2].[O-2].[O-2].[Ce+3].[Ce+3] DRVWBEJJZZTIGJ-UHFFFAOYSA-N 0.000 description 1
- 229940073669 ceteareth 20 Drugs 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- LAAPRQODJPXAHC-AATRIKPKSA-N coniferyl benzoate Chemical compound C1=C(O)C(OC)=CC(\C=C\COC(=O)C=2C=CC=CC=2)=C1 LAAPRQODJPXAHC-AATRIKPKSA-N 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 description 1
- 229940099500 cystamine Drugs 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 1
- GLCJMPWWQKKJQZ-UHFFFAOYSA-L disodium;2-[4-(4,6-disulfonato-1h-benzimidazol-2-yl)phenyl]-1h-benzimidazole-4,6-disulfonate;hydron Chemical compound [Na+].[Na+].C1=C(S(O)(=O)=O)C=C2NC(C3=CC=C(C=C3)C3=NC4=C(C=C(C=C4N3)S(=O)(=O)O)S([O-])(=O)=O)=NC2=C1S([O-])(=O)=O GLCJMPWWQKKJQZ-UHFFFAOYSA-L 0.000 description 1
- PWWSSIYVTQUJQQ-UHFFFAOYSA-N distearyl thiodipropionate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCCCCCCCC PWWSSIYVTQUJQQ-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 125000005908 glyceryl ester group Chemical group 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- PMMXXYHTOMKOAZ-UHFFFAOYSA-N hexadecyl 7-methyloctanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCC(C)C PMMXXYHTOMKOAZ-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 239000004021 humic acid Substances 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000006552 photochemical reaction Methods 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- WZXKPNYMUZGZIA-RMKNXTFCSA-N propyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound CCCOC(=O)\C=C\C1=CC=C(OC)C=C1 WZXKPNYMUZGZIA-RMKNXTFCSA-N 0.000 description 1
- 229960002662 propylthiouracil Drugs 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229940083037 simethicone Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000003458 sulfonic acid derivatives Chemical class 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000019303 thiodipropionic acid Nutrition 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940040064 ubiquinol Drugs 0.000 description 1
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Colloid Chemistry (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Concentrado de emulsión con un contenido de componente (A) oleoso insoluble, emulsificantes (B) hidrofílicos no iónicos, coemulsificantes (C) lipofílicos, polioles (D) y agua, el cual a. contiene menos de 50 % en peso componente (A) oleoso insoluble en agua -referido al peso total del concentrado - b. Contiene los componentes (A), (B), (C) y (D) en la relación de peso A : B : C : D >= 1: (0,25 - 0,6) : (0,25 - 0,6) : (0,45 - 0,65), en el que contiene una fracción acuosa de 35 a 55 % en peso.
Description
5
10
15
20
25
30
35
40
45
50
55
alcanolamonio y glucamonio;
- �
- sal de monosodio de ácido 2,2(-(1,4-fenilen)bis(1 H-bencimidazol-4,6-disulfónico) (Neo Heliopan AP)
- �
- derivados de ácido sulfónico de benzofenonas, preferiblemente ácido 2-hidroxi-4-metoxibenzofenon-5sulfónico y sus sales;
- �
- derivados de ácido sulfónico del 3-bencilidenalcanfor, como por ejemplo ácido 4-(2-oxo-3-bornilidenmetil)bencenosulfónico y ácido 2-metil-5-(2-oxo-3-borniliden)sulfónico y sus sales.
Como filtros UV-A típicos entran en consideración en particular derivados de benzoilmetano, como por ejemplo 1(4’-tert.butilfenil)-3-(4’-metoxifenil)propan-1,3-diona, 4-tert.-butil-4’-metoxidibenzoilmetano (Parsol® 1789), 1-fnil-3(4’-isopropilfenil)-propan-1,3-diona así como compuestos de enamina, como se describen en el documento DE 19712033 A1 (BASF) así como benzoato de 2-[4-(dietilamino)-2-Hidroxibenzoil] hexilo (Uvinul® A plus).
Evidentemente, los filtros UV-A y UV-B pueden ser usados también en mezcla. Combinaciones particularmente convenientes consisten en derivados de benzoilmetano, por ejemplo 4-tert.-butil-4’-metoxidibenzoilmetano (Parsol® 1789) y 2-ciano-3,3-fenilcinamato de 2-etil-hexilo (Octocrileno) en combinación con ésteres de ácido cinámico, preferiblemente 4-metoxicinamato de 2-etilhexilo y/o 4-metoxicinamato de propilo y/o 4-metoxicinamato de isoamilo. De modo ventajoso se combinan tales combinaciones con filtros solubles en agua como por ejemplo ácido 2fenilbencimidazol-5-sulfónico y sus sales alcalinas, alcalinotérreas, de amonio, de alquilamonio, de alcanolamonio y glucamonio.
De acuerdo con la invención se prefieren filtros de luz UV elegidos del anexo VII de la legislación europea de cosméticos (24ª Directiva de la Comisión de Adaptación, 29 de febrero de 2000).
Aparte de las sustancias solubles mencionadas, entran en consideración para este propósito también pigmentos insolubles protectores contra la luz, es decir óxidos metálicos o bien sales finamente dispersos. Son ejemplos de óxidos metálicos adecuados en particular óxido de zinc y dióxido de titanio y además óxidos de hierro, zirconio, silicio, manganeso, aluminio y cerio así como sus mezclas. Como sales pueden usarse silicato (talco), sulfato de bario o estearato de zinc. Los óxidos y sales son usados en forma de pigmentos para emulsiones del cuidado de la piel y protección de la piel y también para cosméticos decorativos. Las partículas deberían exhibir un diámetro promedio inferior a 100 nm, preferiblemente entre 5 y 50 nm y en particular entre 15 y 30 nm. Ellas pueden exhibir una forma esférica, sin embargo pueden estar para el uso también aquellas partículas que posee una forma elipsoidal o de otro modo derivada de la forma esférica. Los pigmentos pueden estar también con tratamiento superficial, es decir transformados en hidrofílicos o hidrófobos. Son ejemplos típicos el dióxido de titanio recubierto, como por ejemplo dióxido de titanio T 805 (Degussa) o Eusolex® T, Eusolex® T-2000, Eusolex® T-Aqua, Eusolex® AVO, Eusolex® T-ECO, Eusolex® T-OLEO y Eusolex® T-S (Merck). Al respecto, como agentes hidrófobos de recubrimiento entran en consideración sobre todo siliconas y al respecto en especial trialcoxioctilsilano o simeticona. En agentes protectores contra el sol se usan preferiblemente los denominados micro o nanopigmentos. Preferiblemente se usa óxido de zinc micronizado. Son ejemplos típicos óxido de zinc, como por ejemplo Óxido de Zinc neutro, Óxido de Zinc NDM (Symrise) o Z-Cote® (BASF) o SUNZnO-AS y SUNZnO-NAS (Sunjun Chemical Co. Ltd.). En la sinopsis de P.Finkel en SÖFW-Journal 122, 543 (1996) así como Parf.Kosm. 3, 11 (1999) se encuentran otros filtros adecuados protectores contra la luz UV.
Aparte de los dos grupos mencionados anteriormente de sustancias primarias protectoras contra la luz, pueden usarse también agentes secundarios protectores contra la luz del tipo de los antioxidantes, que interrumpen la cadena de reacción fotoquímica, que se causa cuando la radiación UV penetra la piel. Son ejemplos típicos de ello los aminoácidos (por ejemplo glicina, histidina, tirosina, triptofano) y sus derivados, imidazoles (por ejemplo ácido urocánico) y sus derivados, péptidos como d,l-carnosina, d-carnosina, l-carnosina y sus derivados (por ejemplo anserina), carotenoides, carotenos (por ejemplo α-caroteno, β-caroteno, licopeno) y sus derivados, ácido clorogénico y sus derivados, ácido lipónico y sus derivados (por ejemplo ácido dihidrolipónico), aurotioglucosa, propiltiouracilo y otros tioles (por ejemplo tioredoxina, glutation, cisteina, cistina, cistamina y sus glicosil-, N-acetil-, metil-, etil-, propil-, amil-, butil-y lauril-, palmitoil-, oleil-, γ-linoleil-, colesteril-y glicerilésteres) así como sus sales, dilauriltiodipropionato, diesteariltiodipropionato, ácido tiodipropionico y sus derivados (ésteres, éteres, péptidos, lípidos, nucleótidos, nucleósidos y sales) así como compuestos de sulfoximina (por ejemplo butioninsulfoximina, homocisteinsulfoximina, butioninsulfona, penta-, hexa-, heptationinsulfoximina) en dosificaciones compatibles muy bajas (por ejemplo pmol a mol/kg), además quelantes(metal) (por ejemplo ácidos α-hidroxigrasos, ácido palmítico, ácido fítico, lactoferrina), α-hidroxiácidos (por ejemplo ácido cítrico, ácido láctico, ácido málico), ácido húmico, ácido galénico, extracto de bilis, bilirubina, biliverdina, EDTA, EGTA y sus derivados, ácidos grasos insaturados y sus derivados (por ejemplo ácido gamma-linolénico, ácido linoleico, ácido oleico), ácido fólico y sus derivados, ubiquinona y ubiquinol y sus derivados, vitamina C y derivados (por ejemplo ascorbilpalmitato, ascorbilfosfato de Mg, ascorbilacetato), tocoferoles y derivados (por ejemplo acetato de vitamina E), vitamina A y derivados (palmitato de vitamina-A-) así como coniferilbenzoato de resina de benjui, ácido rutínico y sus derivados, α-glicosilrutina, ácido
10
5
10
15
20
25
30
35
40
45
50
Producción de los concentrados de emulsión de acuerdo con la invención
La producción de los concentrados de emulsión de acuerdo con la invención ocurre preferiblemente según el método descrito en el documento EP 0723432 B1. Por ello, preferiblemente se elige el componente (A) oleoso insoluble en agua, el emulsificante (B) hidrofílico no iónico y el coemulsificante (C) lipofílico, de modo que las emulsiones producidas con ellos exhiben una temperatura de inversión de fases en el ámbito por debajo de 100°C. Los emulsificantes (B) y coemulsificantes (C) se mezclan con el componente (A) oleoso insoluble en agua y se calientan a 5 °C por encima de la temperatura de in versión de fases. Entonces se añaden agua y poliol (D) aproximadamente a la misma temperatura y se agita -o al revés, se incorpora agitando la mezcla de componente oleoso, emulsificante y coemulsificante en el agua con poliol calentados a 5 °C por encima de la tempe ratura de inversión de fases. De modo alternativo, puede realizarse la producción de la emulsión también por debajo de la temperatura de inversión de fases y llevar entonces la emulsión hasta 5°C por encima de la temperatura de inversión de fases. Después del enfriamiento, se obtiene entonces un concentrado de emulsión de partícula muy fina.
La producción del concentrado de emulsión puede ocurrir según técnicas de generación de emulsión comunes conocidas por los expertos, por ejemplo se menciona la homogenización a alta presión. La producción ocurre preferiblemente según el denominado Método de Inversión de Fases (PIT). En el estado de la técnica se describe la tecnología PIT.
El concentrado de emulsión de acuerdo con la invención exhibe comúnmente una viscosidad mayor a 200 mPas, preferiblemente mayor a 400 mPas (medida con un viscosímetro de rotación Brookfield tipo RVF, aguja 4, 10 rpm, 20°C).
Uso del concentrado de emulsión
Los concentrados de emulsión de acuerdo con la invención pueden ser usados directamente como preparaciones cosméticas. Por ello, otro objetivo de la invención se refiere al uso de los concentrados de emulsión de acuerdo con la invención, como preparaciones cosméticas.
Los concentrados de emulsión de acuerdo con la invención tienen partículas finamente divididas y son muy estables al almacenamiento, por ello son adecuados de manera muy particular como elementos constituyentes de emulsión fabricados con anterioridad, que debido a su fluidez son bien adecuados para el almacenamiento y el transporte a un sitio de procesamiento con poco equipamiento técnico, y así producir con los medios más sencillos emulsiones cosméticas útiles, en particular emulsiones aceite-en-agua.
En consecuencia, un objetivo de la invención se refiere al uso de los concentrados de emulsión de acuerdo con la invención, para la producción de preparaciones cosméticas.
El concentrado de emulsión de acuerdo con la invención es adecuado en particular para la producción de emulsiones cosméticas aceite-en-agua. Al respecto puede incorporarse en el concentrado de emulsión bien sea la fase acuosa continua o la fase lipofílica o ambas, sin suministro adicional de calor.
La fase acuosa, con la que se diluye el concentrado de emulsión, puede contener diluido cualquier componente soluble en agua, por ejemplo principios activos cosméticos solubles en agua, proteínas o productos de degradación de proteína solubles en agua, conservantes, colorantes, aromatizantes, sales de magnesio u otros componentes comunes solubles en agua. Preferiblemente, la fase acuosa continua contiene un polimerizado natural o sintético soluble en agua, el cual mejora las propiedades cosméticas de las emulsiones, mediante aumento de la viscosidad. Una combinación particularmente eficaz de hidrocoloides para el mejoramiento de las propiedades cosméticas de tales emulsiones, es una mezcla de éteres no iónicos de celulosa, por ejemplo hidroxipropilcelulosa y polimerizados entrecruzados de ácido acrílico, como son obtenibles por ejemplo bajo la denominación comercial Carbopol(R) (véase el documento DE 3521713 A1).
La fase lipofílica, con la cual se diluye el concentrado de emulsión, puede contener cualquier componente lipofílico, por ejemplo principios activos cosméticos lipofílicos. Como fase lipofílica son adecuados todos los compuestos adecuados como componente (A).
Por regla general se usa 1 a 50, preferiblemente 2 a 30, en particular 4 a 10 % en peso del concentrado de emulsión, para la producción de las preparaciones cosméticas.
Preparaciones cosméticas
Otro objetivo de la invención se refiere a preparaciones cosméticas que contienen componentes (A) oleosos insolubles en agua, emulsificantes (B) hidrofílicos no iónicos, coemulsificantes (C) lipofílicos, polioles (D) en la relación de peso A: B : C : D = 1: (0,25 -0,6) : (0,25 -0,6) : (0,45 -0,65).
12
- Componente (INCI)
- 1 2 3 4 5 6 V1
- (B)
- Ceteareth-12 1,0 3,0 2,0 1,5 1,5 1,0 1,0
- (B)
- Ceteareth-20 9,0 6,0 10,0 8,0 8,0 8,0 6,5
- Componente (INCI)
- 1 2 3 4 5 6 V1
- (C)
- Cetearil alcohol 7,0 4,0 5,5 4,0 5,0 4,5 7,0
- (C)
- Gliceril estearato 2,0 5,0 5,5 6,0 5,0 4,5 7,0
- (A)
- Cetearil isononanoato 18,0 5,0 14,0 25,0 18,0
- (A)
- Caprilato / caprato de coco 15,0 11,0 12,0
- (A)
- Paraffinum Perliquidum 5,0
- (A)
- Triglicérido caprílico / cáprico 6,0
- (A)
- Isopropil palmitato 11,0
- (D)
- Glicerina 10,0 12,0 10,5 10,0 11,0 11,5 5,0
- Agua
- 53,0 50,0 44,5 51,5 51,5 45,5 55,5
- Ajuste de pH; conservante
- pH 3,0 -3,3; q.s.
- Datos de estabilidad
- 3 meses 40°C estable Separación < 1 semana
- Viscosidad (RT) (Brookfield RVF, aguja 4, 10 rpm), [mPa*s]
- 600 800 900 1800 2000 2500 -
- Viscosidad (40°C) (Brookfield RVF, aguja 4, 10 rpm), [mPa*s]
- 2500 1800 1700 2100 2300 2800 -
- Tamaño de partícula (Coulter LS) [nm]
- 105 110 95 115 110 120 500
Tabla 2
- Relación (A) : (B) : (C) : (D)
- Ejemplo 1
- 1: 0,56 : 0,50 : 0,56
- Ejemplo 2
- 1: 0,45 : 0,45 : 0,6
- Ejemplo 3
- 1: 0,54 : 0,50 : 0,48
- Ejemplo 4
- 1: 0,50 : 0,53 : 0,53
- Ejemplo 5
- 1: 0,53 : 0,55 : 0,61
- Ejemplo 6
- 1: 0,36 : 0,36 : 0,46
- Ejemplo de comparación V1
- 1: 0,42 : 0,77 : 0,28
14
Claims (1)
-
imagen1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06016953A EP1891935A1 (de) | 2006-08-14 | 2006-08-14 | Emulsionskonzentrat |
| EP06016953 | 2006-08-14 | ||
| PCT/EP2007/006918 WO2008019773A1 (de) | 2006-08-14 | 2007-08-06 | Emulsionskonzentrat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2597846T3 true ES2597846T3 (es) | 2017-01-23 |
Family
ID=37605694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES07786569.9T Active ES2597846T3 (es) | 2006-08-14 | 2007-08-06 | Concentrado de emulsión |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9750668B2 (es) |
| EP (2) | EP1891935A1 (es) |
| JP (1) | JP2010504284A (es) |
| KR (1) | KR101473499B1 (es) |
| CN (1) | CN101500537B (es) |
| ES (1) | ES2597846T3 (es) |
| WO (1) | WO2008019773A1 (es) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2191868A1 (de) | 2008-11-28 | 2010-06-02 | Cognis IP Management GmbH | Ethylenoxid-freie Antiperspirant/Desodorant-Zubereitungen |
| EP2206489A1 (de) | 2009-01-08 | 2010-07-14 | Cognis IP Management GmbH | Fließfähige Emulsionskonzentrate |
| ES2415804T3 (es) * | 2010-03-23 | 2013-07-29 | Cognis Ip Management Gmbh | Composición para lavar platos manualmente, suave con la piel |
| WO2013079621A1 (en) * | 2011-11-29 | 2013-06-06 | Art-Fi | Composition simulating the dielectric properties of the human body and use thereof for sar measurement |
| KR101461656B1 (ko) * | 2013-04-18 | 2014-11-20 | 주식회사 리오엘리 | 베이스 화장료 조성물 및 이의 제조방법 |
| EP3067463A1 (en) * | 2015-03-10 | 2016-09-14 | Sasol Wax GmbH | Water based wax dispersion comprising a hydrocarbon wax and a dialkylether for the coating of paper products |
| CN104785160B (zh) * | 2015-04-22 | 2017-03-29 | 中国日用化学工业研究院 | 一种古尔伯特十六烷基三甲基氯化铵阳离子表面活性剂及制备方法 |
| MX371306B (es) | 2015-04-23 | 2020-01-24 | Procter & Gamble | Composiciones concentradas para la limpieza personal y usos. |
| CN107530249B (zh) | 2015-04-23 | 2021-09-07 | 宝洁公司 | 浓缩型个人清洁组合物及方法 |
| WO2016172482A1 (en) | 2015-04-23 | 2016-10-27 | The Procter & Gamble Company | Concentrated personal cleansing compositions and methods |
| MX369415B (es) | 2015-04-23 | 2019-11-07 | Procter & Gamble | Composiciones de limpieza personal concentradas. |
| WO2017025647A1 (en) * | 2015-08-13 | 2017-02-16 | Arch Personal Care Products, Lp | Wet wipe concentrate |
| GB201600778D0 (en) * | 2016-01-15 | 2016-03-02 | Croda Int Plc | Composition,emulsion,method and use |
| US11179301B2 (en) | 2016-10-21 | 2021-11-23 | The Procter And Gamble Company | Skin cleansing compositions and methods |
| US11185486B2 (en) | 2016-10-21 | 2021-11-30 | The Procter And Gamble Company | Personal cleansing compositions and methods |
| US10806686B2 (en) | 2017-02-17 | 2020-10-20 | The Procter And Gamble Company | Packaged personal cleansing product |
| US10675231B2 (en) | 2017-02-17 | 2020-06-09 | The Procter & Gamble Company | Packaged personal cleansing product |
| GB2560209B (en) * | 2017-07-28 | 2020-02-19 | Alchemy Ingredients Ltd | High internal phase emulsions |
| EP3700501A1 (en) * | 2017-10-27 | 2020-09-02 | Cargill, Incorporated | Personal care product |
| CN113164362A (zh) | 2018-12-14 | 2021-07-23 | 高露洁-棕榄公司 | 基于乳液的无有机硅个人护理组合物及用于其的方法 |
| JP7374643B2 (ja) * | 2019-07-26 | 2023-11-07 | 松本油脂製薬株式会社 | 透水性付与剤及びその利用 |
| US11883514B2 (en) | 2019-11-01 | 2024-01-30 | Colgate-Palmolive Company | Stable low pH personal care compositions and methods for the same |
| CA3158619A1 (en) * | 2019-11-01 | 2021-05-06 | Colgate-Palmolive Company | Stable low ph personal care compositions and methods for the same |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1043453A (en) * | 1963-05-15 | 1966-09-21 | Colgate Palmolive Co | Superfatted soap manufacture |
| NZ184181A (en) * | 1976-06-04 | 1979-10-25 | Colgate Palmolive Co | Preparing toilet soap bars comprising poly-(ehtyene oxide) of high molecular weight |
| DE4033928A1 (de) * | 1990-10-25 | 1992-04-30 | Henkel Kgaa | Oel-in-wasser-emulsionen |
| DE4335045A1 (de) * | 1993-10-14 | 1995-04-20 | Henkel Kgaa | Fließfähiges Emulsionskonzentrat |
| DE4426216A1 (de) | 1994-07-23 | 1996-01-25 | Merck Patent Gmbh | Benzyliden-Norcampher-Derivate |
| DE4426215A1 (de) | 1994-07-23 | 1996-01-25 | Merck Patent Gmbh | Ketotricyclo [5.2.1.0] decan-Derivate |
| DE59709127D1 (de) | 1996-07-08 | 2003-02-20 | Ciba Sc Holding Ag | Triazinderivate als UV-Filter in Sonnenschutzmitteln |
| DE19630789A1 (de) * | 1996-07-31 | 1998-02-05 | Basf Ag | Physiologisch wirksame Mengen beta-Carotin-enthaltende klare wäßrig-alkoholische Multivitamin-Lösung |
| DE19712033A1 (de) | 1997-03-21 | 1998-09-24 | Basf Ag | Photostabile UV-Filter enthaltende kosmetische und pharmazeutische Zubereitungen |
| DE19711417A1 (de) * | 1997-03-19 | 1998-09-24 | Henkel Kgaa | Kosmetische Zubereitungen |
| DE19957761A1 (de) * | 1999-12-01 | 2001-06-07 | Beiersdorf Ag | Kosmetische und dermatologische Lichtschutzformulierungen in Form von O/W-Makroemulsionen oder O/W-Mikroemulsionen, mit einem Gehalt an Sheabutter |
| FR2807763A1 (fr) * | 2000-04-17 | 2001-10-19 | Cognis Deutschland Gmbh | Produits de nettoyage aqueux concentres en pate de lavage pour les mains |
| CN1160122C (zh) * | 2001-04-20 | 2004-08-04 | 清华大学 | 一种制备口服胰岛素油相制剂的方法 |
| DE10152304A1 (de) * | 2001-10-26 | 2003-05-08 | Beiersdorf Ag | Glycerin enthaltende kosmetische und dermatologische Zubereitungen auf der Grundlage von O/W-Emulsionen |
| DE10155956A1 (de) * | 2001-11-09 | 2003-05-22 | Beiersdorf Ag | Selbstschäumende, schaumförmige, nachschäumende oder schäumbare kosmetische oder dermatologische Zubereitungen |
| DE10230061A1 (de) * | 2002-07-04 | 2004-01-22 | Beiersdorf Ag | Kosmetische oder dermatologische Formulierungen zur Pflege der Gesichtshaut |
| CN100556407C (zh) * | 2004-01-05 | 2009-11-04 | 沈阳药科大学 | 桂利嗪自乳化胶囊及其制备方法 |
| US9526682B2 (en) | 2004-07-16 | 2016-12-27 | L'oreal | Fine O/W emulsion |
| AU2005279704B2 (en) * | 2004-08-31 | 2010-05-13 | Stiefel Research Australia Pty Ltd | Microemulsion and sub-micron emulsion process and compositions |
| EP1813311A1 (en) * | 2005-11-25 | 2007-08-01 | Cognis IP Management GmbH | Oil-in-water emulsions based on special emulsifiers |
-
2006
- 2006-08-14 EP EP06016953A patent/EP1891935A1/de not_active Withdrawn
-
2007
- 2007-08-06 EP EP07786569.9A patent/EP2051692B1/de active Active
- 2007-08-06 JP JP2009524099A patent/JP2010504284A/ja active Pending
- 2007-08-06 WO PCT/EP2007/006918 patent/WO2008019773A1/de not_active Ceased
- 2007-08-06 US US12/377,553 patent/US9750668B2/en active Active
- 2007-08-06 KR KR1020097002845A patent/KR101473499B1/ko active Active
- 2007-08-06 CN CN2007800301755A patent/CN101500537B/zh active Active
- 2007-08-06 ES ES07786569.9T patent/ES2597846T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2051692A1 (de) | 2009-04-29 |
| KR20090065507A (ko) | 2009-06-22 |
| JP2010504284A (ja) | 2010-02-12 |
| EP2051692B1 (de) | 2016-07-13 |
| EP1891935A1 (de) | 2008-02-27 |
| US9750668B2 (en) | 2017-09-05 |
| CN101500537A (zh) | 2009-08-05 |
| CN101500537B (zh) | 2012-08-22 |
| WO2008019773A1 (de) | 2008-02-21 |
| US20110287073A1 (en) | 2011-11-24 |
| KR101473499B1 (ko) | 2014-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2597846T3 (es) | Concentrado de emulsión | |
| ES2248566T3 (es) | Composiciones para el cuidado personal que contienen polimeros inversores de emulsion. | |
| CN101790367B (zh) | 化妆品乳化剂组合物 | |
| EP1000612B1 (de) | Zubereitungen vom Emulsionstyp W/O mit erhöhtem Wassergehalt, enthaltend ferner ein oder mehrere Alkylmethiconcopolyole und/oder Alkyl-Dimethiconcopolyole sowie kationische Polymere | |
| US11207256B2 (en) | Method for solubilizing poorly water-soluble cosmetic agents | |
| DE19924276A1 (de) | Zubereitungen vom Emulsionstyp W/O mit erhöhtem Wassergehalt, enthaltend ferner ein oder mehrere Alkylmethiconcopolyole und/oder Alky-Dimethiconcopolyole sowie gegebenenfals kationische Polymere | |
| JP2008518988A (ja) | Uv−日焼け止め調製物のための添加剤 | |
| DE10110336A1 (de) | Tensidfreie kosmetische, dermatologische und pharmazeutische Mittel | |
| WO1996002223A1 (de) | Emulgatorfreie, feindisperse kosmetische oder dermatologische zubereitungen vom typ öl-in-wasser | |
| KR20170031711A (ko) | 화장료용 원료 | |
| EP1641904B1 (de) | O/w-emulgator, o/w-emulsion und deren verwendungen | |
| DE102007041493A1 (de) | Pastellfärbung | |
| US20020146438A1 (en) | Preparations of the w/o emulsion type with an increased water content, and comprising cationic polymers | |
| JP5416511B2 (ja) | O/w型日焼け止め化粧料 | |
| DE10048260A1 (de) | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Aminoguanidin und/oder dessen Derivaten und Strukturanaloga zur Hautaufhellung von Altersflecken und/oder zur Verhinderung der Hautbräunung, insbesondere der durch UV-Strahlung hervorgerufenen Hautbräunung | |
| JPH11512410A (ja) | 局所用抗皮膚癌調製物 | |
| EP1094888B1 (de) | Fliessfähige zubereitungen vom emulsionstyp w/o mit erhöhtem wassergehalt | |
| EP0769291B1 (de) | Gegen Akne und entzündete Comedonen wirksame Wirkstoffkombinationen | |
| EP1094889B1 (de) | Fliessfähige zubereitungen vom emulsionstyp w/o mit erhöhtem wassergehalt | |
| DE19802204A1 (de) | Kosmetische oder pharmazeutische Zubereitungen mit vermindertem Klebrigkeitsgefühl, enthaltend Glycerinester von -Hydroxycarbonsäuren und gesättigten Fettsäuren | |
| JPH1067634A (ja) | 界面活性のグルコース誘導体および水溶性uvフイルターを含有する安定な光保護調製物 | |
| ES2223752T3 (es) | Composicion cosmetica que comprende retinol y un compuesto que filtra la radiacion uva. | |
| DE10352369A1 (de) | Verwendung von Licocalchon A oder eines Licocalchon A enthaltenden Extraktes aus Radix Glycyrrhizae inflatae gegen postinflammatorische Hyperpigmentierung | |
| DE19926156A1 (de) | Haarkosmetische Zubereitungen insbesondere solche zur Verbesserung der Kämmbarkeit der Haare auf der Grundlage von Ubichinonen | |
| EP1576950A2 (de) | Tapioka in kosmetischen Zubereitungen |